Catalyst Wire Dossier Catalyst Wire Dossier

rVWF (recombinant von Willebrand factor)

recombinant von Willebrand factor · Shire
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rVWF (recombinant von Willebrand factor), covering 2025-04-30 to 2025-04-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD) [Phase 3]

See pricing